Givlaari
Chemical Name | givosiran |
Dosage Form | Injectable (subcutaneous; 189 mg/mL) |
Drug Class | Oligonucleotides |
System | Digestive |
Company | Alnylam Pharmaceuticals Inc. |
Approval Year | 2019 |
Indication
- Givlaari is indicated for the treatment of adults with acute hepatic porphyria (AHP).